Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Graft Patency”

512 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 512 results

Testing effectiveness (Phase 2)Study completedNCT02500550
What this trial is testing

Safety and Efficacy of Two Doses of ATIR101, a T-lymphocyte Enriched Leukocyte Preparation Depleted of Host Alloreactive T-cells, in Patients With a Hematologic Malignancy Who Received a Hematopoietic Stem Cell Transplantation From a Haploidentical Donor

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaMyelodysplastic Syndrome
Kiadis Pharma 15
Not applicableStudy completedNCT02945176
What this trial is testing

Safety and Performance Study of the ARGOS-IO System in Patients Undergoing Boston Keratoprosthesis Implantation

Who this might be right for
Graft vs Host DiseaseCongenital AniridiaChemical Burns+2 more
Implandata Ophthalmic Products GmbH 13
Large-scale testing (Phase 3)Study completedNCT00210873
What this trial is testing

An Open Label Extension of a Study of Topiramate in Chronic Migraine.

Who this might be right for
Migraine
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 200
Testing effectiveness (Phase 2)Ended earlyNCT00568477
What this trial is testing

Value of Rituximab in Humoral Chronic Rejection After Renal Transplantation

Who this might be right for
GraftingRenal TransplantationTransplantation, Kidney+1 more
Technical University of Munich 200
Testing effectiveness (Phase 2)Looking for participantsNCT06619561
What this trial is testing

Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)

Who this might be right for
Chronic Graft-Versus-Host Disease (cGVHD)
Deciphera Pharmaceuticals, LLC 48
Not applicableStudy completedNCT07386301
What this trial is testing

Open Membrane Technique as an Innovative Minimally Invasive Technique for Bone Augmentation

Who this might be right for
Bone GraftKeratinized Tissue
Saint-Joseph University 16
Testing effectiveness (Phase 2)Study completedNCT00284986
What this trial is testing

Safety and Efficacy of Prochymal for the Salvage of Treatment-Refractory Acute GVHD Participants

Who this might be right for
Graft Versus Host Disease
Mesoblast, Inc. 11
Testing effectiveness (Phase 2)Study completedNCT00013702
What this trial is testing

Adefovir Dipivoxil to Treat Hepatitis B in HIV-Infected Patients

Who this might be right for
Hepatitis BHIV Infection
National Institute of Allergy and Infectious Diseases (NIAID) 30
Not applicableStudy completedNCT06134869
What this trial is testing

Open Membrane Technique as an Innovative Minimally Invasive Technique

Who this might be right for
Bone GraftKeratinized Tissue
Saint-Joseph University 16
Testing effectiveness (Phase 2)Study completedNCT02195869
What this trial is testing

Study of the Bruton's Tyrosine Kinase Inhibitor in Subjects With Chronic Graft Versus Host Disease

Who this might be right for
Graft Versus Host Disease
Pharmacyclics LLC. 45
Post-approval studies (Phase 4)Study completedNCT01334866
What this trial is testing

Graft Patency Outcomes in Patients Undergoing Coronary Artery Bypass Grafting Via Minimally Invasive Coronary Surgery

Who this might be right for
Arteriosclerosis of Coronary Artery Bypass Graft
Medtronic Cardiovascular 91
Testing effectiveness (Phase 2)Looking for participantsNCT07116031
What this trial is testing

Belumosudil in Children With Chronic Graft Versus Host Disease (schoolROCK)

Who this might be right for
Chronic Graft Versus Host Disease
Sanofi 37
Not applicableNot Yet RecruitingNCT07348536
What this trial is testing

Expanded Hemodialysis Versus High-Volume Online Hemodiafiltration for Uremic Toxin Removal

Who this might be right for
End Stage Renal Disease (ESRD)Chronic Kidney Disease on HemodialysisRenal Dialysis+3 more
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 15
Large-scale testing (Phase 3)Looking for participantsNCT06235892
What this trial is testing

Tacrolimus Minimization in Kidney Transplant Recipients Selected According to the AGORA Algorithm for Their Low Immunological Risk and Medium-term Graft Failure

Who this might be right for
Organ Grafts
Nantes University Hospital 300
Testing effectiveness (Phase 2)Ended earlyNCT04941404
What this trial is testing

TQ05105 Tablets in Subjects With Glucocorticoid-Refractory Acute Graft-Versus-Host Disease (aGVHD)

Who this might be right for
Glucocorticoid-Refractory aGVHD
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 13
Post-approval studies (Phase 4)Ended earlyNCT01246011
What this trial is testing

Significance of Antibodies to Heparin/Platelet Factor 4 Complex in Vein Graft Patency and Potential Role of Argatroban for Prevention of Vein Graft Occlusion

Who this might be right for
Coronary Artery Bypass Graft SurgeryPresence of Heparin/Platelet Factor 4 Antibody
Massachusetts General Hospital 9
Not applicableStudy completedNCT04754048
What this trial is testing

Confirm the Safety and Performance of Avance Solo NPWT System

Who this might be right for
Acute WoundTraumatic WoundSkin Graft+3 more
Molnlycke Health Care AB 105
Early research (Phase 1)Study completedNCT02728895
What this trial is testing

Dose Finding Study of Vedolizumab for GvHD in Participants Undergoing Allogeneic HSCT

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplantation
Takeda 24
Testing effectiveness (Phase 2)Study completedNCT00144677
What this trial is testing

Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Un-Related Stem Cell Transplantation

Who this might be right for
Acute Myelogenous LeukemiaGraft Versus Host DiseaseAcute Lymphoblastic Leukemia+4 more
Dana-Farber Cancer Institute 30
Not applicableStudy completedNCT04654728
What this trial is testing

Prospective Randomized Study Comparing ePTFE Versus Dacron Graft for Anterior Sector Venous Drainage in Right Lobe Living Donor Liver Transplantation

Who this might be right for
Patency and Infection Rates Due to Usage of PTFE vs.Dacron Grafts
Istanbul Medipol University Hospital 60
Load More Results